Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
DCFirst Claim
Patent Images
1. A pharmaceutical composition comprising:
- a) from 10% to 95% by weight of total composition of lyophilized Streptococcus thermophilus, andb) from 5% to 90% by weight of total composition of at least one lyophilized bacterium selected from the group consisting of Lactobacillus plantarum and Lactobacillus casei, andc) from 0% to 10% by weight of total composition a pharmaceutically acceptable excipient,wherein said Streptococcus thermophilus and the bacterium b) are present in a concentration of 1×
1011 -1×
1013 total bacteria per gram of the composition.
0 Assignments
Litigations
0 Petitions
Accused Products
Abstract
A pharmaceutical composition containing several different bacteria including Streptococcus thermophilus, Lactobacilli and Bifidobacteria is disclosed. The bacteria are present in the composition at a total concentration of 1×1011 to 1×1013 per gram. Further, methods of using the pharmaceutical are disclosed which include treatment of a gastrointestinal disorder and hypercholesteremia. Also a method for modulating a host'"'"'s immune response is disclosed.
121 Citations
33 Claims
-
1. A pharmaceutical composition comprising:
-
a) from 10% to 95% by weight of total composition of lyophilized Streptococcus thermophilus, and b) from 5% to 90% by weight of total composition of at least one lyophilized bacterium selected from the group consisting of Lactobacillus plantarum and Lactobacillus casei, and c) from 0% to 10% by weight of total composition a pharmaceutically acceptable excipient, wherein said Streptococcus thermophilus and the bacterium b) are present in a concentration of 1×
1011 -1×
1013 total bacteria per gram of the composition. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8)
-
-
9. A pharmaceutical composition comprising:
-
(a) from 30-35% by weight of lyophilized Streptococcus thermophilus; (b) from 7-10% by weight of lyophilized Lactobacillus casei; (c) from 8-10% by weight of lyophilized Lactobacillus plantarum; (d) from 7-10% by weight of lyophilized Lactobacillus acidophilus; (e) from 8-10% by weight of lyophilized Lactobacillus delbrueckii sub-species bulgaricus; (f) from 27-30% by weight of a mixture of lyophilized bifidobacteria; and (g) from 8-10% by weight of a pharmaceutically acceptable excipient, wherein all amounts are based on the total weight of the composition and said bifidobacteria is a mixture of Bifidobacterium longum, Bifidobacterium infantis, and Bifidobacterium bifidum; wherein said excipient is selected from the group consisting of maltodextrin, levulose, microcrystalline cellulose, maize starch, lactose, and dextrose; and wherein said Streptococcus thermophilus, said Lactobacillus casei, and said Lactobacillus plantarum are present in said pharmaceutical composition in a total concentration of 1×
1011 to 1×
1013 bacteria per gram. - View Dependent Claims (10)
-
-
11. A method for treating hypercholesteremia, comprising administering to a patient in need thereof an effective amount of a composition, said composition comprising:
-
(a) from 10 to 95% by weight of total composition of lyophilized Streptococcus thermophilus; (b) from 5 to 90% by weight of total composition of at least one lyophilized bacteria selected from the group consisting of Lactobacillus plantarum and Lactobacillus casei; and (c) from 0 to 10% by weight of total composition of a pharmaceutically acceptable excipient; wherein said Streptococcus thermophilus, Lactobacillus plantarum, and Lactobacillus casei are present in such amounts that the total bacteria concentration in said composition is 1×
1011 to 1×
1013 total bacteria per gram of composition. - View Dependent Claims (12, 13, 14, 15, 16, 17)
-
-
18. A method for treating a gastrointestinal disorder, comprising administering to a patient in need thereof an effective amount of a composition, said composition comprising:
-
(a) from 10 to 95% by weight of total composition of lyophilized Streptococcus thermophilus; (b) from 5 to 90% by weight of total composition of at least one lyophilized bacteria selected from the group consisting of Lactobacillus plantarum and Lactobacillus casei; and (c) from 0 to 10% by weight of total composition of a pharmaceutically acceptable excipient; wherein said Streptococcus thermophilus, Lactobacillus plantarum, and Lactobacillus casei are present in such amounts that the total bacteria concentration in said composition is 1×
1011 to 1×
1013 total bacteria per gram of composition. - View Dependent Claims (19, 20, 21, 22, 23, 24, 25, 26)
-
-
27. A method for modulating a host'"'"'s immune response, comprising administering to a patient in need thereof an effective amount of a composition, said composition comprising:
-
(a) from 10 to 95% by weight of total composition of lyophilized Streptococcus thermophilus; (b) from 5 to 90% by weight of total composition of at least one lyophilized bacteria selected from the group consisting of Lactobacillus plantarum and Lactobacillus casei; and (c) from 0 to 10% by weight of total composition of a pharmaceutically acceptable excipient; wherein said Streptococcus thermophilus, Lactobacillus plantarum, and Lactobacillus casei are present in such amounts that the total bacteria concentration in said composition is 1×
1011 to 1×
1013 total bacteria per gram of composition. - View Dependent Claims (28, 29, 30, 31, 32, 33)
-
Specification